Community Call to Action on Equitable Access to Long-Acting Therapies

The growing pipeline for LAT and their potential to accelerate various disease elimination goals warrants global community mobilization to ensure equitable access. Sign the call to action! More

1 February 2023CABs LAT CAB (2021-present)

Making Diagnosis of Hepatitis C More Accessible and Closer to the Community Using Point-of-Care HCV Viral Load Assays

A key new WHO-led study in collaboration with the University of Bristol showed the benefit of using a quick clinic-based diagnostic test for HCV over a standard laboratory-based test. More

27 January 2023Learn Diagnostics

INHSU 2022 Community Statement

The statement calls for an end to the war on drugs, and for equal access to harm reduction and hepatitis prevention services, regardless of location or drug use status. More

12 December 2022Advocate Policy Statements

Calendar

19 February 2023

CROI 2023

The 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) will take place in Seattle, Washington, USA and virtually, from 19 to 22 February 2023. More

25 April 2023

Global Hepatitis Summit 2023

The Global Hepatitis Summit will take place in Paris, France and virtually, from 25 to 28 April 2023. More

21 May 2023

World Health Assembly 2023

The 76th World Health Assembly will be held from 21 to 30 May 2023. More

21 June 2023

2023 International Liver Congress

2023 International Liver Congress (EASL Congress 2023) will take place in Vienna, Austria and virtually, from 21 to 24 June 2023. More

26 June 2023

Support. Don’t Punish: Global Day of Action

Global Day of Action is the yearly high point of the Support. Don’t Punish campaign, and takes place on 26 June. More

23 July 2023

IAS 2023

The 12th International AIDS Society Conference on HIV Science (IAS 2023) will take place in Brisbane, Australia and virtually, from 23 to 26 July 2023. More

All events

Recent materials

MapCrowd Data Collection Survey

Fill out a short survey regarding the national HCV policy and HCV care continuum services in your country to help collect crucial country-level information for MapCrowd. More

2 February 2023mapCrowd

Integrated Regional Action Plan for Viral Hepatitis, HIV and STIs in South-East Asia, 2022–2026

The Plan shares a common vision to end the epidemics in the South-East Asia Region by 2030 by promoting equity and innovation, and advancing people-centred and community-driven approaches. More

22 January 2023Learn Care

World Falls Short on HBV, HCV Elimination Targets

No countries are on track to meet the goals for HBV eradication by 2030 or 2050, and only 11 countries are on track to achieve all absolute or relative targets for HCV elimination. More

13 November 2022News Partner News

Global State of Harm Reduction 2022

Harm Reduction International released the 8th edition of the Global State of Harm Reduction report, providing an independent analysis of harm reduction in the world. More

7 November 2022Advocate Advocacy Tools

Long-Acting Technologies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria

TAG released a trials tracker providing information on the development of long-acting HCV, malaria, and opioid use and overdose prevention therapy formulations. More

10 August 2022Advocate Advocacy Tools